PABLO J CAGNONI Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for PABLO J CAGNONI.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of PABLO J CAGNONI. PABLO J CAGNONI is in ALLOS THERAPEUTICS INC ($ALTH) and VP of Clinical Affairs in ALLOS THERAPEUTICS INC ($ALTH) and Director in CRISPR Therapeutics AG ($CRSP) and CEO and President in Rubius Therapeutics, Inc. ($RUBY) and Chief Executive Officer in Rubius Therapeutics, Inc. ($RUBY) and Director in Fusion Pharmaceuticals Inc. ($FUSN).
Latest Insider Trading Transactions of PABLO J CAGNONI
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALTH, CRSP, FUSN, RUBY
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 02 2021 | RUBY | Rubius Therapeutic ... | CAGNONI PABLO J | CEO and President | Option Exercise | A | 0.00 | 85,000 | 0 | 85,000 | |
| Feb 02 2021 | RUBY | Rubius Therapeutic ... | CAGNONI PABLO J | CEO and President | Option Exercise | A | 11.97 | 375,000 | 4,488,750 | 375,000 | |
| Jun 30 2020 | FUSN | Fusion Pharmaceuti ... | CAGNONI PABLO J | Director | Option Exercise | A | 17.00 | 30,000 | 510,000 | 30,000 | |
| Apr 15 2020 | RUBY | Rubius Therapeutic ... | CAGNONI PABLO J | CEO and President | Buy | P | 4.70 | 21,000 | 98,694 | 21,000 | 0 to 21 K |
| Feb 03 2020 | RUBY | Rubius Therapeutic ... | CAGNONI PABLO J | Chief Executive Off ... | Option Exercise | A | 7.80 | 500,000 | 3,900,000 | 500,000 | |
| Feb 03 2020 | RUBY | Rubius Therapeutic ... | CAGNONI PABLO J | Chief Executive Off ... | Option Exercise | A | 7.80 | 500,000 | 3,900,000 | 500,000 | |
| Nov 21 2019 | CRSP | CRISPR Therapeutic ... | CAGNONI PABLO J | Director | Option Exercise | M | 5.59 | 7,500 | 41,925 | 63,833 | |
| Nov 21 2019 | CRSP | CRISPR Therapeutic ... | CAGNONI PABLO J | Director | Sell | S | 62.00 | 7,500 | 465,000 | 0 | 7.5 K to 0 (-100.00 %) |
| Nov 21 2019 | CRSP | CRISPR Therapeutic ... | CAGNONI PABLO J | Director | Buy | M | 5.59 | 7,500 | 41,925 | 7,500 | 0 to 7.5 K |
| Nov 01 2019 | CRSP | CRISPR Therapeutic ... | CAGNONI PABLO J | Director | Option Exercise | M | 5.59 | 7,500 | 41,925 | 78,833 | |
| Nov 01 2019 | CRSP | CRISPR Therapeutic ... | CAGNONI PABLO J | Director | Sell | S | 52.00 | 7,500 | 390,000 | 0 | 7.5 K to 0 (-100.00 %) |
| Nov 01 2019 | CRSP | CRISPR Therapeutic ... | CAGNONI PABLO J | Director | Buy | M | 5.59 | 7,500 | 41,925 | 7,500 | 0 to 7.5 K |
| Jun 13 2019 | CRSP | CRISPR Therapeutic ... | CAGNONI PABLO J | Director | Option Exercise | A | 43.52 | 15,000 | 652,800 | 15,000 | |
| Feb 04 2019 | RUBY | Rubius Therapeutic ... | CAGNONI PABLO J | Chief Executive Off ... | Option Exercise | A | 13.69 | 100,000 | 1,369,000 | 100,000 | |
| Nov 01 2018 | RUBY | Rubius Therapeutic ... | CAGNONI PABLO J | Chief Executive Off ... | Option Exercise | A | 16.43 | 193,400 | 3,177,562 | 193,400 | |
| Nov 01 2018 | RUBY | Rubius Therapeutic ... | CAGNONI PABLO J | Chief Executive Off ... | Option Exercise | A | 16.43 | 193,400 | 3,177,562 | 193,400 | |
| Nov 01 2018 | RUBY | Rubius Therapeutic ... | CAGNONI PABLO J | Chief Executive Off ... | Option Exercise | A | 16.43 | 164,400 | 2,701,092 | 164,400 | |
| Nov 01 2018 | RUBY | Rubius Therapeutic ... | CAGNONI PABLO J | Chief Executive Off ... | Option Exercise | A | 16.43 | 164,400 | 2,701,092 | 164,400 | |
| Jul 05 2018 | CRSP | CRISPR Therapeutic ... | CAGNONI PABLO J | Director | Option Exercise | M | 5.59 | 1,684 | 9,414 | 86,333 | |
| Jul 05 2018 | CRSP | CRISPR Therapeutic ... | CAGNONI PABLO J | Director | Option Exercise | M | 5.59 | 5,816 | 32,511 | 88,017 | |
| Jul 05 2018 | CRSP | CRISPR Therapeutic ... | CAGNONI PABLO J | Director | Sell | S | 62.00 | 1,684 | 104,408 | 0 | 1.7 K to 0 (-100.00 %) |
| Jul 05 2018 | CRSP | CRISPR Therapeutic ... | CAGNONI PABLO J | Director | Buy | M | 5.59 | 1,684 | 9,414 | 1,684 | 0 to 1.7 K |
| Jul 05 2018 | CRSP | CRISPR Therapeutic ... | CAGNONI PABLO J | Director | Sell | S | 62.00 | 5,816 | 360,592 | 0 | 5.8 K to 0 (-100.00 %) |
| Jul 05 2018 | CRSP | CRISPR Therapeutic ... | CAGNONI PABLO J | Director | Buy | M | 5.59 | 5,816 | 32,511 | 5,816 | 0 to 5.8 K |
| Jun 15 2018 | CRSP | CRISPR Therapeutic ... | CAGNONI PABLO J | Director | Option Exercise | A | 59.31 | 15,000 | 889,650 | 15,000 | |
| Jun 15 2018 | CRSP | CRISPR Therapeutic ... | CAGNONI PABLO J | Director | Option Exercise | A | 59.31 | 15,000 | 889,650 | 15,000 | |
| Oct 20 2016 | CRSP | CRISPR Therapeutic ... | CAGNONI PABLO J | Director | Option Exercise | A | 14.00 | 15,000 | 210,000 | 15,000 | |
| Aug 13 2004 | ALTH | ALLOS THERAPEUTICS ... | CAGNONI PABLO J | Sell | S | 1.95 | 1,455 | 2,837 | 0 | 1.5 K to 0 (-100.00 %) | |
| Aug 10 2004 | ALTH | ALLOS THERAPEUTICS ... | CAGNONI PABLO J | VP of Clinical Affa ... | Option Exercise | H | 6.00 | 7,976 | 47,856 | 0 | |
| Aug 10 2004 | ALTH | ALLOS THERAPEUTICS ... | CAGNONI PABLO J | VP of Clinical Affa ... | Option Exercise | H | 5.44 | 26,375 | 143,480 | 0 | |
| Aug 10 2004 | ALTH | ALLOS THERAPEUTICS ... | CAGNONI PABLO J | VP of Clinical Affa ... | Option Exercise | H | 4.75 | 27,617 | 131,181 | 0 | |
| Aug 10 2004 | ALTH | ALLOS THERAPEUTICS ... | CAGNONI PABLO J | VP of Clinical Affa ... | Option Exercise | H | 4.75 | 10,063 | 47,799 | 27,617 | |
| Aug 10 2004 | ALTH | ALLOS THERAPEUTICS ... | CAGNONI PABLO J | VP of Clinical Affa ... | Option Exercise | H | 4.52 | 70,561 | 318,936 | 0 | |
| Aug 10 2004 | ALTH | ALLOS THERAPEUTICS ... | CAGNONI PABLO J | VP of Clinical Affa ... | Option Exercise | H | 4.52 | 4,439 | 20,064 | 70,561 | |
| Aug 10 2004 | ALTH | ALLOS THERAPEUTICS ... | CAGNONI PABLO J | VP of Clinical Affa ... | Option Exercise | H | 3.20 | 28,185 | 90,192 | 0 | |
| Aug 10 2004 | ALTH | ALLOS THERAPEUTICS ... | CAGNONI PABLO J | VP of Clinical Affa ... | Option Exercise | H | 3.20 | 1,815 | 5,808 | 28,185 | |
| Aug 10 2004 | ALTH | ALLOS THERAPEUTICS ... | CAGNONI PABLO J | VP of Clinical Affa ... | Option Exercise | H | 2.82 | 57,094 | 161,005 | 0 | |
| Aug 10 2004 | ALTH | ALLOS THERAPEUTICS ... | CAGNONI PABLO J | VP of Clinical Affa ... | Option Exercise | H | 2.82 | 42,906 | 120,995 | 57,094 | |
| Aug 10 2004 | ALTH | ALLOS THERAPEUTICS ... | CAGNONI PABLO J | VP of Clinical Affa ... | Option Exercise | A | 1.78 | 50,000 | 89,000 | 50,000 | |
| Jul 02 2004 | ALTH | ALLOS THERAPEUTICS ... | CAGNONI PABLO J | VP of Clinical Affa ... | Buy | P | 1.91 | 1,455 | 2,783 | 1,455 | 0 to 1.5 K |
| Jun 04 2004 | ALTH | ALLOS THERAPEUTICS ... | CAGNONI PABLO J | VP of Clinical Affa ... | Option Exercise | A | 2.82 | 57,094 | 161,005 | 100,000 | |
| Jun 04 2004 | ALTH | ALLOS THERAPEUTICS ... | CAGNONI PABLO J | VP of Clinical Affa ... | Option Exercise | A | 2.82 | 42,906 | 120,995 | 42,906 | |
| Jun 04 2004 | ALTH | ALLOS THERAPEUTICS ... | CAGNONI PABLO J | VP of Clinical Affa ... | Option Exercise | A | 2.82 | 57,094 | 161,005 | 100,000 | |
| Jun 04 2004 | ALTH | ALLOS THERAPEUTICS ... | CAGNONI PABLO J | VP of Clinical Affa ... | Option Exercise | A | 2.82 | 42,906 | 120,995 | 42,906 | |
| May 18 2004 | ALTH | ALLOS THERAPEUTICS ... | CAGNONI PABLO J | VP of Clinical Affa ... | Sell | S | 2.03 | 1,045 | 2,121 | 0 | 1 K to 0 (-100.00 %) |
| May 18 2004 | ALTH | ALLOS THERAPEUTICS ... | CAGNONI PABLO J | VP of Clinical Affa ... | Sell | S | 2.03 | 1,159 | 2,353 | 1,045 | 2.2 K to 1 K (-52.59 %) |
| Mar 02 2004 | ALTH | ALLOS THERAPEUTICS ... | CAGNONI PABLO J | VP of Clinical Affa ... | Option Exercise | A | 5.44 | 26,375 | 143,480 | 26,375 |
Page: 1